share_log

Greenlight Biosciences And Epivax Therapeutics Signed Exclusive Collaboration Agreement To Develop Personalized Cancer Vaccines

Benzinga Real-time News ·  Jan 9, 2023 07:22

GreenLight Biosciences Holdings, PBC (NASDAQ:GRNA), and EpiVax Therapeutics Inc, today announced that they have signed an exclusive collaboration agreement to jointly develop and commercialize personalized mRNA-based vaccine candidates for cancers.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment